Preventing the Use of Anti-Reflux Medication in Infants Diagnosed with Cleft Palate through Lifestyle Interventions

Update Item Information
Identifier 2022_Madsen
Title Preventing the Use of Anti-Reflux Medication in Infants Diagnosed with Cleft Palate through Lifestyle Interventions
Creator Madsen, Kayley A.; Sylvester, Robert; Clifton, Jennifer
Subject Advanced Nursing Practice; Education, Nursing, Graduate; Infant; Cleft Palate; Cleft Lip; Gastroesophageal Reflux; Comorbidity; Proton Pump Inhibitors; Life Style; Evidence-Based Practice; Outcome Assessment, Health Care; Medication Adherence; Quality Improvement
Description Background: Gastroesophageal reflux is a highly prevalent condition in infants, particularly those with a cleft lip or palate. Children with cleft lip or palate are much more likely to be treated with an anti-reflux medication than the general population of infants. While anti-reflux medication is indicated for infants with certain comorbidities (failure to thrive, esophagitis), it is not a first line treatment for gastroesophageal reflux. Lifestyle interventions can be used to treat reflux and may prevent anti-reflux medication use. Methods: A quality improvement project was developed to help increase the knowledge of gastroesophageal reflux management in parents of children with cleft lip or palate and providers treating these children. An evidence-based educational toolkit was developed for parents to provide education regarding lifestyle interventions used for reflux. Additionally, a toolkit was developed to provide education for providers regarding the management of reflux, including when anti-reflux medications were indicated. Post-education surveys were given to parents and providers to evaluate the effectiveness of the education. Results: Post-intervention, the study found that 82% of parents (n=9) identified that the toolkit gave them alternative ways to treat reflux without medication. Additionally, 100% (n=5) of providers indicated the toolkit was appropriate for the clinic. 80% (n=4) of providers reported they learned the indications for appropriate treatment of reflux with medications. No anti-reflux medication was prescribed during the three months following implementation of the toolkit (January-March 2022). Conclusions: The educational toolkit appears to be a valuable resource to help increase knowledge of gastroesophageal reflux treatment amongst parents and providers. Additional studies are needed to evaluate the effectiveness of the education in a larger sample size.
Relation is Part of Graduate Nursing Project, Doctor of Nursing Practice, DNP, Primary Care FNP
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2022
Type Text
Rights
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Language eng
ARK ark:/87278/s68p2rwz
Setname ehsl_gradnu
ID 1938915
Reference URL https://collections.lib.utah.edu/ark:/87278/s68p2rwz
Back to Search Results